Berlin, Germany

Bernd Elger


 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2005-2010

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Inventor Bernd Elger: Pioneering Pharmaceutical Innovations

Introduction

Bernd Elger, a prominent inventor based in Berlin, Germany, has made significant contributions to the field of pharmaceuticals through his innovative research and development. With a total of three patents, Elger has focused on creating advanced benzimidazole derivatives aimed at treating various diseases. His work reflects a deep commitment to enhancing medical treatments and improving patient outcomes.

Latest Patents

Among his latest inventions, Elger has developed 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, which are integral in the production of pharmaceutical agents. These new benzimidazole derivatives have been described for their role in the treatment and prevention of diseases associated with microglia activation and T-cell-mediated immunological diseases. Furthermore, the pharmaceutical preparations containing these derivatives highlight his dedication to addressing complex health challenges.

Career Highlights

Elger's career has been marked by his contributions to prestigious companies. He has been associated with Schering Aktiengesellschaft and Bayer Schering Pharma AG, where he utilized his expertise to drive pharmaceutical innovation. His work in these organizations has played a pivotal role in advancing therapeutic solutions that align with contemporary medical needs.

Collaborations

Throughout his career, Bernd Elger has collaborated with esteemed peers, including Thorsten Blume and Wolfgang Halfbrodt. These partnerships have fostered a dynamic environment for innovation and have contributed to his successful patent filings and product developments.

Conclusion

In summary, Bernd Elger stands out as a key figure in the realm of pharmaceutical inventions. His innovative work with benzimidazole derivatives showcases his expertise and significant impact on healthcare. As he continues to push the boundaries of science, Elger remains a vital contributor to the advancement of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…